EzriCare leverages technology to develop advancements in pharmaceuticals, making them more effective, safe, and transparent. In the case of our artificial tears eye drops, we developed a formula that has 1% concentration of the active ingredient – carboxymethylcellulose sodium – when compared to the industry standard concentration of 0.5-0.6%., but with 2x the potency.